Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

Related Articles by Review for PubMed (Select 16531613)

1.

Homocysteine lowering with folic acid and B vitamins in vascular disease.

Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J Jr; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators.

N Engl J Med. 2006 Apr 13;354(15):1567-77. Epub 2006 Mar 12. Erratum in: N Engl J Med. 2006 Aug 17;355(7):746.

2.
3.

DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.

Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M; DACH-LIGA Homocystein e.V.

Clin Chem Lab Med. 2003 Nov;41(11):1392-403. Review. Erratum in: Clin Chem Lab Med. 2004 Jan;42(1):113-6.

PMID:
14656016
4.
5.

[Group B vitamins as new variables related to the cardiovascular risk].

Granieri M, Bellisarii FI, De Caterina R.

Ital Heart J Suppl. 2005 Jan;6(1):1-16. Review. Italian.

PMID:
15776726
6.

Homocysteine lowering and cardiovascular disease risk: lost in translation.

Marcus J, Sarnak MJ, Menon V.

Can J Cardiol. 2007 Jul;23(9):707-10. Review.

7.

Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.

Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M.

Z Kardiol. 2004 Jun;93(6):439-53. Review.

PMID:
15252738
8.

Vitamins and minerals 4: overview of folate and the B vitamins.

Thompson J.

Community Pract. 2006 Jun;79(6):197-8. Review.

PMID:
16780289
9.

Hyperhomocysteinemia and cardiovascular risk: effect of vitamin supplementation in risk reduction.

Ciaccio M, Bellia C.

Curr Clin Pharmacol. 2010 Feb;5(1):30-6. Review.

PMID:
20236081
10.

The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis.

Potter K, Hankey GJ, Green DJ, Eikelboom J, Jamrozik K, Arnolda LF.

BMC Cardiovasc Disord. 2008 Sep 20;8:24. doi: 10.1186/1471-2261-8-24. Review.

11.

[Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].

Sydow K, Böger RH.

Z Kardiol. 2001 Jan;90(1):1-11. Review. German.

PMID:
11220081
12.

Vitamins, homocysteine and cardiovascular risk.

Graham IM, O'Callaghan P.

Cardiovasc Drugs Ther. 2002 Sep;16(5):383-9. Review.

PMID:
12652107
13.

[Hyperhomocysteinemia and cardiometabolic risk].

Vannucchi H, Melo SS.

Arq Bras Endocrinol Metabol. 2009 Jul;53(5):540-9. Review. Portuguese.

14.

The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis.

Jardine MJ, Kang A, Zoungas S, Navaneethan SD, Ninomiya T, Nigwekar SU, Gallagher MP, Cass A, Strippoli G, Perkovic V.

BMJ. 2012 Jun 13;344:e3533. doi: 10.1136/bmj.e3533. Review.

15.

[Homocysteine and diabetic macroangiopathy].

Araki A.

Nihon Rinsho. 2006 Nov;64(11):2153-8. Review. Japanese.

PMID:
17087311
16.

The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease?

Abraham JM, Cho L.

Cleve Clin J Med. 2010 Dec;77(12):911-8. doi: 10.3949/ccjm.77a.10036. Review.

18.

The controversial role of B-vitamins in cardiovascular risk: An update.

Ntaios G, Savopoulos C, Grekas D, Hatzitolios A.

Arch Cardiovasc Dis. 2009 Dec;102(12):847-54. doi: 10.1016/j.acvd.2009.07.002. Review.

19.

Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.

Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE, Bønaa KH, Spence JD, Nygård O, Jamison R, Gaziano JM, Guarino P, Bennett D, Mir F, Peto R, Collins R; B-Vitamin Treatment Trialists' Collaboration.

Arch Intern Med. 2010 Oct 11;170(18):1622-31. doi: 10.1001/archinternmed.2010.348. Review.

PMID:
20937919
20.

Homocysteine and cardiovascular disease: a review of the evidence.

Wierzbicki AS.

Diab Vasc Dis Res. 2007 Jun;4(2):143-50. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk